DFT, molecular docking and receptor inhibition analysis of neuromodulatory molecule- dopamine
Current Pharmaceutical Analysis · 2025-05 · 21 (5) · 271-280
DOI: 10.1016/j.cpan.2025.04.003 ↗Kurz gefasst
Fachartikel in der Zeitschrift Current Pharmaceutical Analysis, 2025-05. Verfasst von Noushi Zaidi und 4 weiteren Autor:innen. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Deanship of Scientific Research, King Khalid University, King Faisal University.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Förderung
- Deanship of Scientific Research, King Khalid University
- King Faisal University
Zitieren
APA
Zaidi, N., Mir, M. A., Chang, S. K., Abdelli, N., & Andrews, K. (2025). DFT, molecular docking and receptor inhibition analysis of neuromodulatory molecule- dopamine. Current Pharmaceutical Analysis, 21(5), 271-280. https://doi.org/10.1016/j.cpan.2025.04.003
Vancouver
Zaidi N, Mir MA, Chang SK, Abdelli N, Andrews K. DFT, molecular docking and receptor inhibition analysis of neuromodulatory molecule- dopamine. Current Pharmaceutical Analysis. 2025;21(5):271-280. doi:10.1016/j.cpan.2025.04.003
BibTeX
@article{Zaidi2025,
author = {Zaidi, Noushi and Mir, M. Amin and Chang, Sook Keng and Abdelli, Nouara and Andrews, K.},
title = {DFT, molecular docking and receptor inhibition analysis of neuromodulatory molecule- dopamine},
journal = {Current Pharmaceutical Analysis},
year = {2025},
volume = {21},
number = {5},
pages = {271--280},
doi = {10.1016/j.cpan.2025.04.003}
}
EUVIMED